全文获取类型
收费全文 | 3838篇 |
免费 | 460篇 |
国内免费 | 163篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 206篇 |
妇产科学 | 13篇 |
基础医学 | 269篇 |
口腔科学 | 43篇 |
临床医学 | 182篇 |
内科学 | 444篇 |
皮肤病学 | 35篇 |
神经病学 | 14篇 |
特种医学 | 85篇 |
外国民族医学 | 1篇 |
外科学 | 273篇 |
综合类 | 424篇 |
预防医学 | 238篇 |
眼科学 | 8篇 |
药学 | 1471篇 |
2篇 | |
中国医学 | 379篇 |
肿瘤学 | 371篇 |
出版年
2024年 | 8篇 |
2023年 | 99篇 |
2022年 | 73篇 |
2021年 | 219篇 |
2020年 | 183篇 |
2019年 | 199篇 |
2018年 | 196篇 |
2017年 | 179篇 |
2016年 | 171篇 |
2015年 | 151篇 |
2014年 | 206篇 |
2013年 | 401篇 |
2012年 | 230篇 |
2011年 | 218篇 |
2010年 | 158篇 |
2009年 | 132篇 |
2008年 | 154篇 |
2007年 | 164篇 |
2006年 | 139篇 |
2005年 | 148篇 |
2004年 | 123篇 |
2003年 | 104篇 |
2002年 | 104篇 |
2001年 | 87篇 |
2000年 | 83篇 |
1999年 | 60篇 |
1998年 | 35篇 |
1997年 | 37篇 |
1996年 | 27篇 |
1995年 | 32篇 |
1994年 | 31篇 |
1993年 | 26篇 |
1992年 | 34篇 |
1991年 | 42篇 |
1990年 | 41篇 |
1989年 | 19篇 |
1988年 | 28篇 |
1987年 | 18篇 |
1986年 | 19篇 |
1985年 | 12篇 |
1984年 | 9篇 |
1983年 | 13篇 |
1982年 | 9篇 |
1981年 | 9篇 |
1980年 | 13篇 |
1979年 | 6篇 |
1978年 | 8篇 |
1977年 | 2篇 |
1976年 | 1篇 |
1975年 | 1篇 |
排序方式: 共有4461条查询结果,搜索用时 62 毫秒
1.
Shinichi Tsuruta Kenichi Kohashi Yuichi Yamada Minako Fujiwara Yutaka Koga Eikichi Ihara Yoshihiro Ogawa Eiji Oki Masafumi Nakamura Yoshinao Oda 《Cancer science》2020,111(3):1008-1019
ARID1A, one of the subunits in SWI/SNF chromatin remodeling complex, is frequently mutated in gastric cancers with microsatellite instability (MSI). The most frequent MSI in solid‐type poorly differentiated adenocarcinoma (PDA) has been reported, but the SWI/SNF complex status in solid‐type PDA is still largely unknown. We retrospectively analyzed 54 cases of solid‐type PDA for the expressions of mismatch repair (MMR) proteins (MLH1, PMS2, MSH2, and MSH6), SWI/SNF complex subunits (ARID1A, INI1, BRG1, BRM, BAF155, and BAF170) and EBER, and mutations in KRAS and BRAF. We analyzed 40 cases of another histological type of gastric cancer as a control group. The solid‐type PDAs showed coexisting glandular components (76%), MMR deficiency (39%), and complete/partial loss of ARID1A (31%/7%), INI1 (4%/4%), BRG1 (48%/30%), BRM (33%/33%), BAF155 (13%/41%), and BAF170 (6%/2%), EBER positivity (4%), KRAS mutation (2%), and BRAF mutation (2%). Compared to the control group, MMR deficiency and losses of ARID1A, BRG1, BRM, and BAF155 were significantly frequent in solid‐type PDAs. Mismatch repair deficiency was associated with the losses of ARID1A, BRG1, and BAF155 in solid‐type PDAs. In the MMR‐deficient group, solid components showed significantly more frequent losses of ARID1A, BRG1, BRM, and BAF155 compared to glandular components (P = .0268, P = .0181, P = .0224, and P = .0071, respectively). In the MMR‐proficient group, solid components showed significantly more frequent loss of BRG1 compared to glandular components (P = .012). In conclusion, solid‐type PDAs showed frequent losses of MMR proteins and the SWI/SNF complex. We suggest that loss of the SWI/SNF complex could induce a morphological shift from differentiated‐type adenocarcinoma to solid‐type PDA. 相似文献
2.
3.
4.
Sebastian P. Mondaca MD Dazhi Liu PharmD BCOP Jessica R. Flynn Sandy Badson Stefan Hamaway BS Mrinal M. Gounder MD Danny N. Khalil MD PhD Alexander E. Drilon MD Bob T. Li MD MPH Komal L. Jhaveri MD Alison M. Schram MD Katherine E. Kargus RN Mary Kate Kasler DNP MSN Natalie M. Blauvelt Neil H. Segal MD PhD Marinela Capanu PhD Margaret K. Callahan MD PhD David M. Hyman MD Maya Gambarin-Gelwan MD James J. Harding MD 《Cancer》2020,126(22):4967-4974
5.
Antoine Lin Hlne Sudour‐Bonnange Virginie Languillat‐Fouquet Herv Brisse Sabine Irtan Arnauld Verschuur Sabine Sarnacki Estelle Thbaud Aurore Coulomb‐L'Hermine Anne Notz‐Carrre Jean Michon Marie‐Dominique Tabone Ccile Boulanger Isabelle Pellier Claire Freycon Georges Audry Frdrique Dijoud Magali Morelle Christophe Bergeron Claudia Pasqualini 《Pediatric blood & cancer》2020,67(6)
6.
目的:对6个厂家不同氢溴酸右美沙芬口服固体制剂进行体外溶出度考察,比较体外溶出情况,为临床用药提供参考。方法:采用转篮法,转速100 r·min-1,用高效液相色谱法测定氢溴酸右美沙芬口服固体制剂在0.1 mol·L-1盐酸溶液中的溶出曲线;以威布尔方程拟合溶出参数T50、Td、m,并对参数进行方差分析。结果:氢溴酸右美沙普通片、分散片、胶囊以及软胶囊的平均累积溶出度分别为94.3%、101.3%、105.2%、93.4%。溶出参数T50、Td差异较大,其中T50最大的是最小的13.4倍。结论:氢溴酸右美沙片、分散片、胶囊以及软胶囊体外溶出行为差别大,产品质量存在较大差异。 相似文献
7.
8.
Calcified tissue is a common component of atherosclerotic plaques, and occurs most often in mature plaques. The process of calcification is a poorly understood risk factor that may contribute to a plaque's vulnerability to sudden rupture. In this study a solid-state imaging sequence, termed single-point imaging (SPI), was used to observe calcification directly in ex vivo atherosclerotic plaques. Standards were used to validate the ability of (31)P SPI to detect and differentiate calcification from crystalline cholesterol, phospholipids, and other plaque components. After suitable experimental parameters were found, human carotid specimens obtained by endarterectomy were imaged ex vivo by (31)P solid-state imaging and standard (1)H methods. In contrast to (1)H imaging methods, (31)P imaging detected only the calcification in the plaque. 相似文献
9.
沙利度胺治疗肝癌的实验研究 总被引:1,自引:0,他引:1
目的研究沙利度胺对肝癌的治疗作用。方法采用小鼠肝癌移植性模型。观察沙利度胺对实体型和腹水型肿瘤的治疗作用。结果沙利度胺按每日200mg/kg连续给药10d,能明显抑制肝癌实体型肿瘤的生长,不降低小鼠血细胞数及淋巴细胞增殖;对腹水型肿瘤小鼠虽无明显生命延长作用,但沙利度胺与阿霉素联合用药对肝癌实体型及腹水型均有协调抗肿瘤作用,且可阻止阿霉素造成的小鼠血细胞减少、免疫功能降低。沙利度胺日剂量200mg/kg能明显增加肿瘤组织坏死,促进肿瘤组织边缘淋巴细胞侵润。结论沙利度胺对小鼠肝癌有确切治疗作用,与阿霉素联合用药效果更好。 相似文献
10.
R.A. Fisher 《Transplant infectious disease》2009,11(3):195-202
Abstract: As the most prevalent pathogen among transplant patients, cytomegalovirus (CMV) affects up to three-quarters of all solid organ transplant recipients. While we have made great strides in preventing CMV infection and disease in the early post-transplant period, late CMV infection and indirect effects due to viral immunomodulation remain problematic. Changing immunosuppression practices, including the increasing use of T-cell depleting induction antibodies, have the potential to affect the risk for CMV infection and disease, even in the face of good prophylactic and preemptive therapy. The purpose of this review article is to discuss the impact of CMV infection on long-term allograft outcomes and to re-evaluate the risks and management strategies for prevention of CMV in the framework of evolving modern immunosuppressive strategies. 相似文献